Yamashita N, Morita M, Yokota H, Mimori-Kiyosue Y
Methods Mol Biol. 2024; 2872:51-72.
PMID: 39616568
DOI: 10.1007/978-1-0716-4224-5_4.
Griffiths C, Shah M, Shao W, Borgman C, Janes K
Sci Adv. 2024; 10(46):eadp6303.
PMID: 39536108
PMC: 11559625.
DOI: 10.1126/sciadv.adp6303.
Soni D, Anjum Z, Raza K, Verma S
Cell Biochem Biophys. 2024; 82(2):575-591.
PMID: 38724755
DOI: 10.1007/s12013-024-01281-1.
Li S, Shu Q, Zhou H, Liu Y, Fan M, Liang X
Nat Commun. 2024; 15(1):3901.
PMID: 38724505
PMC: 11082251.
DOI: 10.1038/s41467-024-48288-z.
Griffiths C, Shah M, Shao W, Borgman C, Janes K
bioRxiv. 2024; .
PMID: 38585853
PMC: 10996681.
DOI: 10.1101/2024.03.28.587274.
Pip5k1γ regulates axon formation by limiting Rap1 activity.
Meo D, Kundu T, Ravindran P, Shah B, Puschel A
Life Sci Alliance. 2024; 7(5).
PMID: 38438249
PMC: 10912816.
DOI: 10.26508/lsa.202302383.
Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation.
Lee J, Chatterjee A, Scarpa M, Bailey C, Niyongere S, Singh P
Cancer Res Commun. 2024; 4(2):431-445.
PMID: 38284896
PMC: 10870818.
DOI: 10.1158/2767-9764.CRC-23-0379.
Cholesterol biosynthetic pathway induces cellular senescence through ERRα.
Ziegler D, Czarnecka-Herok J, Vernier M, Scholtes C, Camprubi C, Huna A
NPJ Aging. 2024; 10(1):5.
PMID: 38216569
PMC: 10786911.
DOI: 10.1038/s41514-023-00128-y.
RSK3 switches cell fate: from stress-induced senescence to malignant progression.
Huna A, Flaman J, Lodillinsky C, Zhu K, Makulyte G, Pakulska V
J Exp Clin Cancer Res. 2023; 42(1):318.
PMID: 38008756
PMC: 10680185.
DOI: 10.1186/s13046-023-02909-5.
DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer.
Miller A, Perurena N, Gardner A, Hinoue T, Loi P, Laird P
Cancer Res. 2023; 83(11):1800-1814.
PMID: 36939385
PMC: 10236151.
DOI: 10.1158/0008-5472.CAN-22-0370.
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer.
Kumari A, Gesumaria L, Liu Y, Hughitt V, Zhang X, Ceribelli M
JCI Insight. 2023; 8(5).
PMID: 36883564
PMC: 10077471.
DOI: 10.1172/jci.insight.156657.
Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms.
Maugeri A, Calderaro A, Patane G, Navarra M, Barreca D, Cirmi S
Int J Mol Sci. 2023; 24(3).
PMID: 36769274
PMC: 9918234.
DOI: 10.3390/ijms24032952.
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer.
Rose M, Espinoza V, Hoff K, Pike L, Sharma V, Hofmann M
Cancers (Basel). 2023; 15(2).
PMID: 36672327
PMC: 9856535.
DOI: 10.3390/cancers15020378.
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.
Wang L, Jin H, Jochems F, Wang S, Lieftink C, Martinez I
Nat Cancer. 2022; 3(11):1284-1299.
PMID: 36414711
DOI: 10.1038/s43018-022-00462-2.
Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway.
Ghoneum A, Gonzalez D, Afify H, Shu J, Hegarty A, Adisa J
Cancers (Basel). 2022; 14(20).
PMID: 36291886
PMC: 9600774.
DOI: 10.3390/cancers14205099.
Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Vitali L, Merlini A, Galvagno F, Proment A, Sangiolo D
Biomedicines. 2022; 10(10).
PMID: 36289890
PMC: 9599827.
DOI: 10.3390/biomedicines10102628.
Hyper-active RAS/MAPK introduces cancer-specific mitotic vulnerabilities.
Herman J, Romain R, Hoellerbauer P, Shirnekhi H, King D, DeLuca K
Proc Natl Acad Sci U S A. 2022; 119(41):e2208255119.
PMID: 36191188
PMC: 9565228.
DOI: 10.1073/pnas.2208255119.
Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.
Erol A
Cancer Manag Res. 2022; 14:2339-2356.
PMID: 35958947
PMC: 9362849.
DOI: 10.2147/CMAR.S373557.
Sanguinarine Inhibition of TNF-α-Induced CCL2, IKBKE/NF-κB/ERK1/2 Signaling Pathway, and Cell Migration in Human Triple-Negative Breast Cancer Cells.
Messeha S, Zarmouh N, Antonie L, Soliman K
Int J Mol Sci. 2022; 23(15).
PMID: 35955463
PMC: 9368383.
DOI: 10.3390/ijms23158329.
IKKε Inhibitor Amlexanox Promotes Olaparib Sensitivity through the C/EBP-β-Mediated Transcription of Rad51 in Castrate-Resistant Prostate Cancer.
Gilbert S, Peant B, Mes-Masson A, Saad F
Cancers (Basel). 2022; 14(15).
PMID: 35954347
PMC: 9367422.
DOI: 10.3390/cancers14153684.